Ilex Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Ilex Capital Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.75M	Buy	+22,637	New	+$5.28M	0.12%	71

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ilex Capital Partners's JNJ Position: Q2 2026 in Review

Ilex Capital Partners opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 22,637 shares worth $5.75M. The stake represents 0.12% of the portfolio and ranks #71 among its holdings.

4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Ilex Capital Partners held 22,637 shares of Johnson & Johnson worth $5.75M as of Q2 2026.
Johnson & Johnson was a new Ilex Capital Partners position in Q2 2026.
Johnson & Johnson made up 0.12% of Ilex Capital Partners's portfolio in Q2 2026, its #71 holding.
4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ilex Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.